The controlling shareholder of Star Lake Bioscience (600866.SH) has completed the increase in holding of the company's 0.68% stake.
Star Lake Technology (600866.SH) has announced that its controlling shareholder, Guangdong Guangxin Holdings Group Co., Ltd. (abbreviated as...)
Star Lake Bioscience (600866.SH) announced that the controlling shareholder Guangdong Guangxin Holding Group Co., Ltd. (referred to as "Guangxin Group") has completed the implementation of its share increase plan. Guangxin Group has acquired a total of 11.3018 million shares of the company through centralized competitive bidding on the Shanghai Stock Exchange, representing 0.68% of the total share capital of the company. The total amount of the share increase is RMB 51.2965 million. This share increase plan has been completed.
Related Articles

MINSHENG EDU (01569): HKIAC makes a partial ruling ordering the respondent to fulfill the relevant terms of the SPA.

BRAINAURORA-B (06681) signs a brain health digital AI technology service cooperation agreement with Macau Mirror Lake Hospital.

China Securities Co., Ltd.: The spring market is expected to continue after the Spring Festival, it is recommended to hold onto stocks during the festival.
MINSHENG EDU (01569): HKIAC makes a partial ruling ordering the respondent to fulfill the relevant terms of the SPA.

BRAINAURORA-B (06681) signs a brain health digital AI technology service cooperation agreement with Macau Mirror Lake Hospital.

China Securities Co., Ltd.: The spring market is expected to continue after the Spring Festival, it is recommended to hold onto stocks during the festival.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


